As on Thursday, Kairos Pharma Ltd (AMEX: KAPA) got off with the flyer as it spiked 16.88% to $0.97, before settling in for the price of $0.83 at the close. Taking a more long-term approach, KAPA posted a 52-week range of $0.40-$3.25.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -23.37%. Meanwhile, its Annual Earning per share during the time was -23.37%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -8.39%. This publicly-traded company’s shares outstanding now amounts to $20.82 million, simultaneously with a float of $12.06 million. The organization now has a market capitalization sitting at $20.20 million. At the time of writing, stock’s 50-day Moving Average stood at $0.8287, while the 200-day Moving Average is $0.9351.
Kairos Pharma Ltd (KAPA) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Kairos Pharma Ltd’s current insider ownership accounts for 42.08%, in contrast to 2.14% institutional ownership.
Kairos Pharma Ltd (KAPA) Earnings and Revenue Records
Kairos Pharma Ltd’s EPS decrease for this current 12-month fiscal period is -8.39% and is forecasted to reach -0.33 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -22.09% through the next 5 years, which can be compared against the -23.37% growth it accomplished over the previous five years trading on the market.
Kairos Pharma Ltd (AMEX: KAPA) Trading Performance Indicators
Let’s observe the current performance indicators for Kairos Pharma Ltd (KAPA). It’s Quick Ratio in the last reported quarter now stands at 16.56.
In the same vein, KAPA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.30, a figure that is expected to reach -0.02 in the next quarter, and analysts are predicting that it will be -0.33 at the market close of one year from today.
Technical Analysis of Kairos Pharma Ltd (KAPA)
Through scrutinizing the latest numbers posted by the [Kairos Pharma Ltd, KAPA], it can be observed that its last 5-days Average volume of 0.27 million was better the volume of 0.27 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 86.59% While, its Average True Range was 77.13.
Raw Stochastic average of Kairos Pharma Ltd (KAPA) in the period of the previous 100 days is set at 21.05%, which indicates a major fall in contrast to 80.56% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0673 that was lower than 0.0983 volatility it exhibited in the past 100-days period.
